PubMed Health⌕ Search

Biomedical subjects

J M Hittner

Publications and source records attributed to J M Hittner.

2 recordsLinked to original sources

Beta-amyloid(1-40) effects on behavior and memory.

Beta amyloid 1-40 is a primary protein in plaques found in the brains of patients with Alzheimer's disease. There is evidence that unaggregated soluble beta-amyloid may be neurotoxic and may have behavioral effects on some types of memory. In the current study, the 1-40 fragment of beta-amyloid protein (beta A4), or vehicle, was bilaterally injected into the rostral hippocampus of rats performing under stable food-maintained schedules of reinforcement or under a delayed conditional discrimination procedure. Under the first procedure, rats were trained to stability under a multiple fixed interval 15 s, fixed ratio 30 reinforcement schedule. This reinforcement schedule has proven sensitive to low-dose drug effects. Acute bilateral hippocampal beta A4 (1.0, 2.0 and 3.0 microliters of 10(-3) M) administration did not significantly alter responding, compared to vehicle, under either reinforcement condition. Following the acute single-injection regimen, rats were administered chronic daily beta A4 (1 microliter of 10(-3) M), bilaterally, for 15 days. No significant changes in lever-pressing performance were observed during the chronic injection regimen, but performance declined significantly 30 days after termination of the chronic daily regimen. Histological examination revealed three of six rats showed positive reactions under Thioflavin S staining in and around the area of cannulae termination. The second assessment employed a delayed conditional discrimination procedure to evaluate the effects of intrahippocampal injections of beta A4 on short-term working memory. This conditional discrimination procedure assesses appropriate responding, dependent on a previously presented stimulus, after delays of various lengths have been imposed between the stimulus and the response opportunity.(ABSTRACT TRUNCATED AT 250 WORDS)

Amyloid beta-Peptides↗

Effects of the Ca2+ channel antagonist flunarizine on visual discrimination learning.

Recent studies report that the peripheral administration of Ca2+ channel antagonists improves memory while central administration impairs memory in neurologically intact subjects. This study compares the effects of systemic versus central administration of the Ca2+ channel antagonist flunarizine on visual discrimination learning. In Experiment 1, 60 five-day-old male chicks received an intraperitoneal injection of 0, 1, 10, or 25 mg/kg flunarizine. Each chick then received three post-treatment test sessions (+5 min, +30 min, and +24 h) consisting of 60 visual discrimination trials followed by 5 min of observation in an open field. Flunarizine produced a dose- and time-dependent facilitation of learning. Evaluation of open-field behaviors indicated that the dose of flunarizine required to increase spontaneous activity was 10 times higher than the dose required to facilitate visual discrimination learning. No other open-field behaviors were effected. In Experiment 2, 44 chicks received intracerbroventricular injections of 0, 100 nM, 100 micro M, or 1 mM flunarizine followed by visual discrimination training as described in Experiment 1. Ventricular injection of flunarizine significantly increased the number of errors made during acquisition and retention trials. These data are consistent with earlier studies showing that systemic, but not central, administration of Ca2+ channel antagonists facilitates learning.

Animals↗